ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

OLUX-E
Topical steroids
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

OLUX-E Rx

Generic Name and Formulations:
Clobetasol propionate 0.05%; emulsion aerosol foam.

Company:
Mylan Inc.

Therapeutic Use:

Indications for OLUX-E:

Corticosteroid-responsive dermatoses.

Adult:

≥12yrs: apply thin layer to affected area(s) twice daily (AM & PM); max 50g/week or 21 capfuls/week and 2 consecutive week's treatment per course. Discontinue when control is achieved. Wash hands after application. Do not occlude.

Children:

<12yrs: not recommended.

Warnings/Precautions:

Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axillae, groin, or other intertriginous areas. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Product is flammable. Pregnancy. Nursing mothers.

Pharmacological Class:

Corticosteroid.

Adverse Reactions:

Burning, stinging, pruritus, erythema, skin atrophy, folliculitis, dermal cracking and fissuring, telangiectasia, striae; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.

How Supplied:

Foam—50g, 100g

Sign Up for Free e-newsletters



CME Focus